Joint Filer Information
Names: | Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Healthcare Innovations Fund, L.P. |
Address: | 345 Park avenue South, 12th Floor New York, NY 10010 |
Designated Filer: | James E. Flynn |
Issuer and Ticker Symbol: | Mirum Pharmaceuticals, Inc. [MIRM] |
Date of Event Requiring Statement: | June 6, 2022 |
The undersigned, Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P. are jointly filing the attached Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of Mirum Pharmaceuticals, Inc.
Signatures:
DEERFIELD MGMT HIF, L.P.
By: J.E. Flynn Capital HIF, LLC, General Partner
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| DEERFIELD MGMT IV, L.P.
By: J.E. Flynn Capital IV, LLC, General Partner
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
DEERFIELD MANAGEMENT COMPANY, L.P.
By: Flynn Management LLC, General Partner
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| DEERFIELD PRIVATE DESIGN FUND IV, L.P.
By: Deerfield Mgmt IV, L.P., General Partner
By: J.E. Flynn Capital IV, LLC, General Partner
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
|
DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.
By: Deerfield Mgmt HIF, L.P., General Partner
By: J.E. Flynn Capital HIF, LLC, General Partner
By: /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |